Aemetis, Inc. (NASDAQ:AMTX) Receives Average Recommendation of “Moderate Buy” from Analysts

Aemetis, Inc. (NASDAQ:AMTX) has earned a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $12.95.

A number of equities analysts have issued reports on the company. HC Wainwright restated a “buy” rating and set a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research report on Friday.

Hedge Funds Weigh In On Aemetis

A number of institutional investors have recently modified their holdings of the company. Geode Capital Management LLC grew its position in Aemetis by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares during the period. State Street Corp lifted its stake in shares of Aemetis by 36.1% in the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after buying an additional 185,304 shares in the last quarter. Susquehanna Fundamental Investments LLC grew its holdings in shares of Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after buying an additional 93,536 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Aemetis during the second quarter worth about $306,000. Finally, Wellington Management Group LLP acquired a new stake in shares of Aemetis in the 3rd quarter worth about $177,000. 27.02% of the stock is owned by institutional investors and hedge funds.

Aemetis Stock Up 5.3 %

AMTX stock opened at $2.97 on Monday. The firm has a market cap of $147.71 million, a price-to-earnings ratio of -1.31 and a beta of 1.47. The company’s fifty day simple moving average is $3.27 and its 200 day simple moving average is $2.97. Aemetis has a 12-month low of $2.10 and a 12-month high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same period in the prior year, the firm earned ($0.59) earnings per share. Research analysts expect that Aemetis will post -2.02 earnings per share for the current year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.